Wang Xihong, Morris-Natschke Susan L, Lee Kuo-Hsiung
Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Med Res Rev. 2007 Jan;27(1):133-48. doi: 10.1002/med.20077.
Tanshen, the rhizome of Salvia miltiorrhiza Bunge, has been used in Chinese traditional medicine (TCM) for multiple therapeutic remedies. The major constituents of Tanshen include water-soluble phenolic acids and lipophilic tanshinones. Phenolic acids possess antioxidant and anticoagulant activities, whereas tanshinones show antibacterial, antioxidant, and antineoplastic activities. This review will focus on recent developments concerning the chemical constituents of Tanshen and their biological activities. These chemical and biological studies continue to increase our understanding about a scientific basis for the traditional clinical use of Tanshen and can also contribute to the development of new drug candidates. Recently, in the author's laboratory, a new compound, neo-tanshinlactone, was discovered to have potent selective antibreast cancer activity. This compound might serve as a lead for developing promising antibreast cancer clinical trials candidates.
丹参,即丹参的根茎,在中国传统医学(TCM)中被用于多种治疗方法。丹参的主要成分包括水溶性酚酸和亲脂性丹参酮。酚酸具有抗氧化和抗凝活性,而丹参酮具有抗菌、抗氧化和抗肿瘤活性。本综述将聚焦于丹参化学成分及其生物活性的最新进展。这些化学和生物学研究不断增进我们对丹参传统临床应用科学依据的理解,也有助于开发新的候选药物。最近,在作者的实验室中,发现了一种新化合物——新丹参内酯,具有强大的选择性抗乳腺癌活性。该化合物可能成为开发有前景的抗乳腺癌临床试验候选药物的先导物。